Efferon LPS
Efferon LPS is a medical device with 10 clinical trials. Currently 2 active trials ongoing. Historical success rate of 75.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
75.0%
3 of 4 finished
25.0%
1 ended early
2
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Hemoadsorpion in Patients With Septic Shock: Efficacy and Safety Evaluation
Efferon LPS Hemoadsorption in in Patients With Thermal Burns
Efferon LPS Hemoadsorption in Cardiac Surgery Patients
Lipopolysaccharide Adsorption (Efferon LPS) in Patients With Ulcerative Colitis and Crohn Disease
Lipopolysaccharide Adsorption (Efferon LPS) in Patients With Thermal Burns
Clinical Trials (10)
Hemoadsorpion in Patients With Septic Shock: Efficacy and Safety Evaluation
Efferon LPS Hemoadsorption in in Patients With Thermal Burns
Efferon LPS Hemoadsorption in Cardiac Surgery Patients
Lipopolysaccharide Adsorption (Efferon LPS) in Patients With Ulcerative Colitis and Crohn Disease
Lipopolysaccharide Adsorption (Efferon LPS) in Patients With Thermal Burns
Hemoperfusion Efferon LPS During Cardiac Surgery Using Cardiopulmonary Bypass
Efferon LPS Hemoadsorption in Patients With Acute Pancreatitis
Selective Lipopolysaccharide Hemosorption in Maternal Sepsis
Combined Hemoperfusion and Therapeutic Plasma Exchange for Treatment of Patients With Septic Shock
Efferon LPS Hemoperfusion for Treatment of Patients With Septic Shock
All 10 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 10